Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2012
10/23/2012US8293948 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
10/23/2012US8293924 Process for the preparation of carbapenem antibiotic
10/23/2012US8293922 Processes of preparing glycolurils and cucurbiturils using microwave
10/23/2012US8293903 3-aminocyclopentanecarboxamides as chemokine receptor agonists
10/23/2012US8293769 CSF-1R inhibitors, compositions, and methods of use
10/23/2012US8293747 Heterocyclic amide compounds as protein kinase inhibitors
10/23/2012US8293732 Antibacterial quinoline derivatives
10/23/2012US8293731 HIV integrase inhibitors
10/23/2012US8293730 Substituted imidazo[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives
10/23/2012US8293139 Charge transport compositions and electronic devices made with such compositions
10/23/2012CA2555279C Azepinoindole derivatives as pharmaceutical agents
10/23/2012CA2439263C Three hybrid assay system
10/18/2012WO2012142237A1 Fused imidazole derivatives useful as ido inhibitors
10/18/2012WO2012141704A1 Compounds for the treatment of hepatitis c
10/18/2012WO2012141604A1 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
10/18/2012WO2012141197A1 Organic electroluminescence element
10/18/2012WO2012141038A1 Synthesis and analysis of novel compound capable of inducing differentiation of human mesenchymal stem cell into hepatocyte
10/18/2012WO2012139693A1 Compounds for electronic devices
10/18/2012WO2012139692A1 Materials for electronic devices
10/18/2012WO2012139455A1 Intermediates of ticagrelor and method for preparing ticagrelor
10/18/2012US20120264768 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
10/18/2012US20120264751 Pyrrolopyrazoles, potent kinase inhibitors
10/18/2012US20120264739 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
10/18/2012US20120264738 Dispiropyrrolidine derivatives
10/18/2012US20120264737 Heterocyclic Modulators of Lipid Synthesis
10/18/2012US20120264736 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
10/18/2012US20120264733 Heterocyclic compound and use thereof
10/18/2012US20120264725 Substituted porphyrins
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263675 Bivalent diazo bicyclic smac
10/18/2012US20120261650 Organic electroluminescent device
10/18/2012US20120260825 Polymeric dispersants
10/18/2012CA2833296A1 Fused imidazole derivatives useful as ido inhibitors
10/18/2012CA2831388A1 Asymmetrically substituted anthrapyridazone derivatives as cytostatics
10/17/2012EP2511277A2 Synthesis of 8-aminoboron-dipyrromethenes having blue fluorescence
10/17/2012EP2511276A1 Pyrrolo[2,3-d]pyrimidine derivative
10/17/2012EP2510946A1 Conjugates of synthetic tlr agonists and uses therefor
10/17/2012EP2509983A1 FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY
10/17/2012EP2509982A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
10/17/2012EP2509981A1 Inhibitors of diacylglycerol acyltransferase
10/17/2012EP2509980A1 Heterocyclic compounds containing an indole core
10/17/2012EP2509979A1 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
10/17/2012EP2509974A1 Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer
10/17/2012EP2509597A1 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/17/2012EP2509424A1 Novel oxadiazole compounds
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741257A Spiroindolinone pyrrolidines
10/17/2012CN102741256A Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
10/17/2012CN102741255A Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
10/17/2012CN102741253A Pi3k (delta) selective inhibitors
10/17/2012CN102741250A Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors
10/17/2012CN102731513A Method for extracting sodium copper chlorophyllin from wild deyeuxia angustifolia forage grass
10/17/2012CN102731512A Preparation method of lurasidone intermediate and lurasidone
10/17/2012CN102731511A Synthesizing method of [1,2,4] triazolo [1,5-a] pyrazine
10/17/2012CN102731510A Derivatives of ticagerlor, and preparation method and pharmaceutical application thereof
10/17/2012CN102731509A 5-aryl-6-o-toluidino-4H-imidazo[1, 2-b]-1, 2 , 4-triazole
10/17/2012CN102731492A Cyclohexane derivative, its preparation method and its application in medicines
10/17/2012CN102731467A Novel intermediate of ticagrelor and method for preparing ticagrelor
10/17/2012CN102731416A 1-(aryl methyl)-quinazoline-2,4-dione as PARP inhibitor and its application
10/17/2012CN102093365B Method for producing 4-hydroxy-6-methyl-1,3,3a,7-tetraazaindene
10/17/2012CN101870698B Sulfonyl-phenyl imidazo triazine derivative and preparation method
10/17/2012CN101565556B Preparation method for solvent orange 60
10/16/2012US8288536 Kinase inhibitors
10/16/2012US8288529 Geometric synthesis of porphyrin rods
10/16/2012US8288528 Meso-substituted porphyrins
10/16/2012US8288431 Substituted spiroindolinones
10/16/2012US8288425 Benzimidazoles
10/16/2012US8288400 Compositions useful as inhibitors of protein kinases
10/16/2012US8288399 Medicine containing pyrimidine derivative
10/16/2012US8288397 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
10/16/2012US8288396 Pyrimidopyrimidoindazole derivative
10/16/2012US8288395 Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
10/16/2012US8288375 Fungicidal bicyclic pyrazoles
10/16/2012US8287839 Low toxicity boronated porphyrins for use in the treatment, visualization, and diagnosis of tumors via boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT); brain, head and neck tumors; diagnosis
10/16/2012US8287769 Charge transport compositions and electronic devices made with such compositions
10/16/2012CA2605680C Substituted amide derivatives as protein kinase inhibitors
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2526884C P2x7 receptor antagonists and their use
10/11/2012WO2012138981A2 New intermediates and processes for preparing ticagrelor
10/11/2012WO2012138945A1 Methods of treating schizophrenia with pyrazole derivative inhibitors of tgf - beta
10/11/2012WO2012137111A1 Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
10/11/2012WO2012137089A1 Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases
10/11/2012WO2012136933A1 Process for obtaining a charge of hexanitrohexaazaisowurtzitane crystals having a rounded morphology; charge and corresponding energetic material
10/11/2012WO2012136776A1 Imidazopyridazines as akt kinase inhibitors
10/11/2012WO2012136772A1 Fused pyrrole derivates as estrogen receptor ligands
10/11/2012WO2012136751A1 N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
10/11/2012WO2012136622A1 Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
10/11/2012WO2012136553A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
10/11/2012WO2012135944A1 Protein kinase inhibitors
10/11/2012WO2012135937A1 Protein kinase inhibitors
10/11/2012WO2012111027A3 Process for pemetrexed disodium
10/11/2012WO2012096929A3 Heteroaryl compounds and methods of use thereof
10/11/2012WO2012083306A3 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
10/11/2012WO2012076886A3 Process for the preparation of semiconductor materials, compounds and their use
10/11/2012WO2012035549A3 An improved process for the synthesis of beta amino acid derivatives
10/11/2012WO2011117668A9 Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
10/11/2012US20120259129 Process for Preparing Azabicyclic Compounds
10/11/2012US20120259115 Pyrrolo[2,3-d]pyrimidine derivatives: their intermediates and synthesis
10/11/2012US20120259112 Methods for the synthesis of polycyclic guanidine compounds
10/11/2012US20120258977 Inhibitors of e1 activating enzymes
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 573